Sino Biopharmaceutical (SMZ1) Income Statement

Last quarter (Q4 2024), Sino Biopharmaceutical's total revenue was ¥6.50B, a decrease of -14.96% from the same quarter last year. In Q4, Sino Biopharmaceutical's net income was ¥241.34M. See Sino Biopharmaceutical’s key income statements, including revenue, expenses, profit, and income.